- Home
- PACK vs VSTM Comparison
PACK vs VSTM Comparison
Compare PACK & VSTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PACK | VSTM |
|---|---|---|
| Founded | 1972 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Containers/Packaging | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 303.3M | 470.7M |
| IPO Year | 2017 | 2011 |
Fundamental Metrics
Financial Performance| Metric | PACK | VSTM |
|---|---|---|
| Price | $3.75 | $6.08 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 7 |
| Target Price | $6.50 | ★ $16.50 |
| AVG Volume (30 Days) | 338.1K | ★ 2.1M |
| Earning Date | 05-05-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 17.49 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $395,000,000.00 | $30,914,000.00 |
| Revenue This Year | $9.29 | $282.64 |
| Revenue Next Year | $8.35 | $72.25 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | 7.08 | ★ 209.14 |
| 52 Week Low | $2.91 | $4.01 |
| 52 Week High | $6.31 | $11.25 |
Technical Indicators
Market Signals| Indicator | PACK | VSTM |
|---|---|---|
| Relative Strength Index (RSI) | 47.42 | 58.45 |
| Support Level | $3.36 | $6.01 |
| Resistance Level | $3.79 | $6.79 |
| Average True Range (ATR) | 0.16 | 0.39 |
| MACD | 0.09 | 0.09 |
| Stochastic Oscillator | 71.03 | 97.40 |
Price Performance
Historical ComparisonAbout PACK Ranpak Holdings Corp
Ranpak Holdings Corp is a provider of environmentally sustainable, systems-based, product protection solutions for e-Commerce and industrial supply chains. The company offers a full suite of protective packaging systems and paper consumables. The group generates revenue by providing its PPS systems and paper consumables to customers, which include direct end-users and a network of exclusive paper packaging solution distributors, and by providing end-of-line automation systems that solve challenges, including optimization, customization, and efficiency. It has two segments, North America and Europe/Asia.
About VSTM Verastem Inc.
Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.